Nemaura Medical (NMRD) Stock Price, News & Analysis

Company Overview

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.05
• Volume: 360 shs
• Average Volume: 7,983 shs
• Market Capitalization: $4.04 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Nemaura Medical Stock Analysis - MarketRank™

Nemaura Medical scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Nemaura Medical.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Nemaura Medical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nemaura Medical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Nemaura Medical has been sold short.

Short Interest Ratio / Days to Cover

Nemaura Medical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nemaura Medical does not currently pay a dividend.

Dividend Growth

Nemaura Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.5 / 5
• Environmental Score: -0.97

Percentage of Shares Shorted

0.00% of the float of Nemaura Medical has been sold short.

Short Interest Ratio / Days to Cover

Nemaura Medical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nemaura Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

40.42% of the stock of Nemaura Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 4.41% of the stock of Nemaura Medical is held by institutions.

NMRD Stock Analysis - Frequently Asked Questions

How have NMRD shares performed this year?

Nemaura Medical's stock was trading at $0.0001 at the beginning of the year. Since then, NMRD stock has increased by 0.0% and is now trading at $0.0001.

How were Nemaura Medical's earnings last quarter?

Nemaura Medical Inc. (NASDAQ:NMRD) announced its quarterly earnings results on Monday, February, 12th. The company reported ($0.12) earnings per share (EPS) for the quarter.

How do I buy shares of Nemaura Medical?

Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Nemaura Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nemaura Medical investors own include Ford Motor (F), Pfizer (PFE), Meta Platforms (META), Exxon Mobil (XOM), Agile Therapeutics (AGRX) and Tesla (TSLA).

Company Calendar

• Last Earnings: 2/12/2024
• Today: 8/27/2025
• Next Earnings (Estimated): 9/29/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:NMRD
• CIK: 1602078
• Web: nemauramedical.com
• Phone: (646) 416-8000
• Fax: N/A
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $3.02 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.41) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 40,352,000
• Free Float: 24,042,000
• Market Cap: $4 thousand
• Optionable: No Data
• Beta: 0.60